Year |
Citation |
Score |
2024 |
Sefik E, Duan K, Li Y, Sholar B, Evans L, Pincus J, Ammar Z, Murphy MM, Klaiman C, Saulnier CA, Pulver SL, Goldman-Yassen AE, Guo Y, Walker EF, Li L, ... Mulle JG, et al. Structural deviations of the posterior fossa and the cerebellum and their cognitive links in a neurodevelopmental deletion syndrome. Molecular Psychiatry. PMID 38744992 DOI: 10.1038/s41380-024-02584-8 |
0.623 |
|
2024 |
Sefik E, Guest RM, Aberizk K, Espana R, Goines K, Novacek DM, Murphy MM, Goldman-Yassen AE, Cubells JF, Ousley O, Li L, Shultz S, Walker EF, Mulle JG. Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity. Psychiatry Research. 335: 115867. PMID 38537595 DOI: 10.1016/j.psychres.2024.115867 |
0.733 |
|
2023 |
Pollak RM, Tilmon JC, Murphy MM, Gambello MJ, Sanchez Russo R, Dormans JP, Mulle JG. Musculoskeletal phenotypes in 3q29 deletion syndrome. American Journal of Medical Genetics. Part A. 191: 2749-2756. PMID 37691301 DOI: 10.1002/ajmg.a.63384 |
0.371 |
|
2023 |
Purcell RH, Sefik E, Werner E, King AT, Mosley TJ, Merritt-Garza ME, Chopra P, McEachin ZT, Karne S, Raj N, Vaglio BJ, Sullivan D, Firestein BL, Tilahun K, Robinette MI, ... ... Mulle JG, et al. Cross-species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion. Science Advances. 9: eadh0558. PMID 37585521 DOI: 10.1126/sciadv.adh0558 |
0.757 |
|
2023 |
Pollak RM, Burrell TL, Cubells JF, Klaiman C, Murphy MM, Saulnier CA, Walker EF, White SP, Mulle JG. Visual-Motor Integration Deficits in 3q29 Deletion Syndrome. Journal of Autism and Developmental Disorders. PMID 37354284 DOI: 10.1007/s10803-023-06034-2 |
0.477 |
|
2023 |
Yilmaz F, Gurusamy U, Mosley TJ, Hallast P, Kim K, Mostovoy Y, Purcell RH, Shaikh TH, Zwick ME, Kwok PY, Lee C, Mulle JG. High level of complexity and global diversity of the 3q29 locus revealed by optical mapping and long-read sequencing. Genome Medicine. 15: 35. PMID 37165454 DOI: 10.1186/s13073-023-01184-5 |
0.365 |
|
2023 |
Pollak RM, Tilmon JC, Murphy MM, Gambello MJ, Sanchez Russo R, Dormans JP, Mulle JG. Musculoskeletal phenotypes in 3q29 deletion syndrome. Medrxiv : the Preprint Server For Health Sciences. PMID 37066183 DOI: 10.1101/2023.04.03.23288084 |
0.36 |
|
2023 |
Pollak RM, Lindsey Burrell T, Cubells JF, Klaiman C, Murphy MM, Saulnier CA, Walker EF, White SP, Mulle JG. Adaptive behavior deficits in individuals with 3q29 deletion syndrome. Medrxiv : the Preprint Server For Health Sciences. PMID 37066139 DOI: 10.1101/2023.03.31.23288022 |
0.566 |
|
2023 |
Purcell RH, Sefik E, Werner E, King AT, Mosley TJ, Merritt-Garza ME, Chopra P, McEachin ZT, Karne S, Raj N, Tilahun K, Robinette M, Warren ST, Wen Z, Faundez V, ... ... Mulle JG, et al. Cross-species transcriptomic analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion. Biorxiv : the Preprint Server For Biology. PMID 36747819 DOI: 10.1101/2023.01.27.525748 |
0.762 |
|
2022 |
Pollak RM, Pincus JE, Burrell TL, Cubells JF, Klaiman C, Murphy MM, Saulnier CA, Walker EF, White SP, Mulle JG. Autism spectrum disorder symptom expression in individuals with 3q29 deletion syndrome. Molecular Autism. 13: 50. PMID 36566217 DOI: 10.1186/s13229-022-00533-2 |
0.522 |
|
2022 |
Biedziak B, Dąbrowska J, Szponar-Żurowska A, Bukowska-Olech E, Jamsheer A, Mojs E, Mulle J, Płoski R, Mostowska A. Identification of a new familial case of 3q29 deletion syndrome associated with cleft lip and palate via whole-exome sequencing. American Journal of Medical Genetics. Part A. PMID 36317839 DOI: 10.1002/ajmg.a.63015 |
0.411 |
|
2022 |
Kozlova A, Zhang S, Kotlar AV, Jamison B, Zhang H, Shi S, Forrest MP, McDaid J, Cutler DJ, Epstein MP, Zwick ME, Pang ZP, Sanders AR, Warren ST, Gejman PV, ... Mulle JG, et al. Loss of function of OTUD7A in the schizophrenia- associated 15q13.3 deletion impairs synapse development and function in human neurons. American Journal of Human Genetics. 109: 1500-1519. PMID 35931052 DOI: 10.1016/j.ajhg.2022.07.001 |
0.576 |
|
2022 |
Pollak RM, Purcell RH, Rutkowski TP, Malone T, Pachura KJ, Bassell GJ, Epstein MP, Dawson PA, Smith MR, Jones DP, Zwick ME, Warren ST, Caspary T, Weinshenker D, Mulle JG. Metabolic effects of the schizophrenia-associated 3q29 deletion. Translational Psychiatry. 12: 66. PMID 35177588 DOI: 10.1038/s41398-022-01824-1 |
0.569 |
|
2021 |
Glassford MR, Purcell RH, Pass S, Murphy MM, Bassell GJ, Mulle JG. Caregiver Perspectives on a Child's Diagnosis of 3q29 Deletion: "We Can't Just Wish This Thing Away". Journal of Developmental and Behavioral Pediatrics : Jdbp. PMID 34320535 DOI: 10.1097/DBP.0000000000000977 |
0.307 |
|
2021 |
Trevino CE, Holleman AM, Corbitt H, Maslen CL, Rosser TC, Cutler DJ, Johnston HR, Rambo-Martin BL, Oberoi J, Dooley KJ, Capone GT, Reeves RH, Cordell HJ, Keavney BD, Agopian AJ, ... ... Mulle JG, et al. Author Correction: Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome. Scientific Reports. 11: 15164. PMID 34285246 DOI: 10.1038/s41598-021-94021-x |
0.747 |
|
2021 |
Sefik E, Purcell RH, Walker EF, Bassell GJ, Mulle JG. Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome. Translational Psychiatry. 11: 357. PMID 34131099 DOI: 10.1038/s41398-021-01435-2 |
0.756 |
|
2021 |
Sanchez Russo R, Gambello MJ, Murphy MM, Aberizk K, Black E, Burrell TL, Carlock G, Cubells JF, Epstein MT, Espana R, Goines K, Guest RM, Klaiman C, Koh S, Leslie EJ, ... ... Mulle JG, et al. Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 33564151 DOI: 10.1038/s41436-020-01053-1 |
0.721 |
|
2021 |
Sefik E, Aberizk K, Espana R, Guest R, Goines K, Novacek D, Pincus J, Murphy M, Li L, Shultz S, Walker E, Mulle J. Structural Cerebellar Correlates of Psychotic and Sub-Threshold Psychotic Symptoms in the 3q29 Deletion Syndrome Biological Psychiatry. 89: S225-S226. DOI: 10.1016/j.biopsych.2021.02.569 |
0.677 |
|
2020 |
Trevino CE, Holleman AM, Corbitt H, Maslen CL, Rosser TC, Cutler DJ, Johnston HR, Rambo-Martin BL, Oberoi J, Dooley KJ, Capone GT, Reeves RH, Cordell HJ, Keavney BD, Agopian AJ, ... ... Mulle JG, et al. Identifying genetic factors that contribute to the increased risk of congenital heart defects in infants with Down syndrome. Scientific Reports. 10: 18051. PMID 33093519 DOI: 10.1038/s41598-020-74650-4 |
0.786 |
|
2020 |
Murphy MM, Burrell TL, Cubells JF, Epstein MT, Espana R, Gambello MJ, Goines K, Klaiman C, Koh S, Russo RS, Saulnier CA, Walker E, Mulle JG. Comprehensive phenotyping of neuropsychiatric traits in a multiplex 3q29 deletion family: a case report. Bmc Psychiatry. 20: 184. PMID 32321479 DOI: 10.1186/S12888-020-02598-W |
0.596 |
|
2020 |
Pollak RM, Zinsmeister MC, Murphy MM, Zwick ME, Mulle JG. New phenotypes associated with 3q29 duplication syndrome: Results from the 3q29 registry. American Journal of Medical Genetics. Part A. PMID 32154651 DOI: 10.1002/Ajmg.A.61540 |
0.453 |
|
2020 |
Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, ... ... Mulle JG, et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Molecular Psychiatry. PMID 32015465 DOI: 10.1038/S41380-020-0654-3 |
0.67 |
|
2019 |
Sanders SJ, Sahin M, Hostyk J, Thurm A, Jacquemont S, Avillach P, Douard E, Martin CL, Modi ME, Moreno-De-Luca A, Raznahan A, Anticevic A, Dolmetsch R, Feng G, Geschwind DH, ... ... Mulle JG, et al. A framework for the investigation of rare genetic disorders in neuropsychiatry. Nature Medicine. PMID 31548702 DOI: 10.1038/S41591-019-0581-5 |
0.372 |
|
2019 |
Pollak RM, Murphy MM, Epstein MP, Zwick ME, Klaiman C, Saulnier CA, Mulle JG. Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry. Molecular Autism. 10: 30. PMID 31346402 DOI: 10.1186/S13229-019-0281-5 |
0.475 |
|
2019 |
Holleman AM, Broadaway KA, Duncan R, Todor A, Almli LM, Bradley B, Ressler KJ, Ghosh D, Mulle JG, Epstein MP. Powerful and Efficient Strategies for Genetic Association Testing of Symptom and Questionnaire Data in Psychiatric Genetic Studies. Scientific Reports. 9: 7523. PMID 31101869 DOI: 10.1038/S41598-019-44046-0 |
0.351 |
|
2019 |
Rutkowski TP, Purcell RH, Pollak RM, Grewenow SM, Gafford GM, Malone T, Khan UA, Schroeder JP, Epstein MP, Bassell GJ, Warren ST, Weinshenker D, Caspary T, Mulle JG. Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion. Molecular Psychiatry. PMID 30976085 DOI: 10.1038/S41380-019-0413-5 |
0.645 |
|
2019 |
Wang AW, Avramopoulos D, Lori A, Mulle J, Conneely K, Powers A, Duncan E, Almli L, Massa N, McGrath J, Schwartz AC, Goes FS, Weng L, Wang R, Yolken R, et al. Genome-wide association study in two populations to determine genetic variants associated with Toxoplasma gondii infection and relationship to schizophrenia risk. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30610941 DOI: 10.1016/J.Pnpbp.2018.12.019 |
0.411 |
|
2019 |
Pollak R, Purcell R, Rutkowski T, Malone T, Pachura K, Bassell GJ, Epstein MP, Caspary T, Dawson PA, Jones DP, Warren ST, Weinshenker D, Zwick ME, Mulle JG. T11Metabolic Dysfunction As A Contributor To Phenotypes Of The Schizophrenia-Associated 3Q29 Deletion European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.08.210 |
0.63 |
|
2019 |
Sefik E, Purcell R, Bassell GJ, Walker E, Mulle J. M55 WEIGHTED GENE CO-EXPRESSION NETWORK ANALYSIS OF THE HUMAN FRONTAL CORTEX REVEALS NOVEL INSIGHTS INTO THE SCHIZOPHRENIA-ASSOCIATED 3Q29 DELETION SYNDROME European Neuropsychopharmacology. 29: S195. DOI: 10.1016/J.Euroneuro.2019.08.155 |
0.746 |
|
2019 |
Pollak R, Boddu S, Park J, Zwick M, Saulnier C, Mulle J. The Emory 3Q29 Deletion Project: Profiles Of Neurodevelopmental And Neuropsychiatric Phenotypes European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.087 |
0.354 |
|
2018 |
Murphy MM, Lindsey Burrell T, Cubells JF, España RA, Gambello MJ, Goines KCB, Klaiman C, Li L, Novacek DM, Papetti A, Sanchez Russo RL, Saulnier CA, Shultz S, Walker E, Mulle JG. Study protocol for The Emory 3q29 Project: evaluation of neurodevelopmental, psychiatric, and medical symptoms in 3q29 deletion syndrome. Bmc Psychiatry. 18: 183. PMID 29884173 DOI: 10.1186/S12888-018-1760-5 |
0.627 |
|
2018 |
Pollak R, Murphy M, Epstein M, Zwick M, Saulnier C, Mulle J. F64. The Neuropsychiatric and Behavioral Phenotypes of 3q29 Deletion Syndrome Biological Psychiatry. 83: S262. DOI: 10.1016/J.Biopsych.2018.02.677 |
0.371 |
|
2018 |
Rutkowski T, Schroeder J, Gafford G, Grewenow S, Malone T, Warren S, Mulle J, Weinshenker D, Caspary T. T224. A Mouse Model of the 3q29 Deletion Biological Psychiatry. 83: S215. DOI: 10.1016/J.Biopsych.2018.02.561 |
0.568 |
|
2017 |
Rambo-Martin BL, Mulle JG, Cutler DJ, Bean LJH, Rosser TC, Dooley KJ, Cua C, Capone G, Maslen CL, Reeves RH, Sherman SL, Zwick ME. Analysis of Copy Number Variants on Chromosome 21 in Down Syndrome-Associated Congenital Heart Defects. G3 (Bethesda, Md.). PMID 29141989 DOI: 10.1534/G3.117.300366 |
0.793 |
|
2017 |
Johnston HR, Chopra P, Wingo TS, Patel V, Epstein MP, Mulle JG, Warren ST, Zwick ME, Cutler DJ. Reply to Plüss et al.: The strength of PEMapper/PECaller lies in unbiased calling using large sample sizes. Proceedings of the National Academy of Sciences of the United States of America. PMID 28916730 DOI: 10.1073/Pnas.1714535114 |
0.532 |
|
2017 |
Johnston HR, Chopra P, Wingo TS, Patel V, Epstein MP, Mulle JG, Warren ST, Zwick ME, Cutler DJ. PEMapper and PECaller provide a simplified approach to whole-genome sequencing. Proceedings of the National Academy of Sciences of the United States of America. PMID 28223510 DOI: 10.1073/Pnas.1618065114 |
0.542 |
|
2017 |
Lori A, Avramopoulos D, Wang A, Goes FS, Mulle J, Powers A, McGrath JJ, Massa N, Weng L, Duncan E, Nestadt G, Conneely K, Wolyniec P, Wang R, Hopkins M, et al. 917. Genome-Wide Association Study (GWAS) of Toxoplasma Gondii Infection and Evaluation of Schizophrenia Risk by Using a Polygenic Risk Score (PRS) Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.643 |
0.364 |
|
2016 |
Rutkowski TP, Schroeder JP, Gafford GM, Warren ST, Weinshenker D, Caspary T, Mulle JG. Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders. Journal of Neuroscience Research. PMID 27859486 DOI: 10.1002/Jnr.23970 |
0.664 |
|
2016 |
Bernstein AI, Lin Y, Street RC, Lin L, Dai Q, Yu L, Bao H, Gearing M, Lah JJ, Nelson PT, He C, Levey AI, Mullé JG, Duan R, Jin P. 5-hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity. Human Molecular Genetics. PMID 27060332 DOI: 10.1093/Hmg/Ddw109 |
0.44 |
|
2016 |
Glassford MR, Rosenfeld JA, Freedman AA, Zwick ME, Mulle JG. Novel features of 3q29 deletion syndrome: Results from the 3q29 registry. American Journal of Medical Genetics. Part A. PMID 26738761 DOI: 10.1002/Ajmg.A.37537 |
0.479 |
|
2015 |
Kotlar AV, Mercer KB, Zwick ME, Mulle JG. New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings. European Journal of Medical Genetics. PMID 26493318 DOI: 10.1016/J.Ejmg.2015.10.008 |
0.427 |
|
2015 |
Goes FS, McGrath J, Avramopoulos D, Wolyniec P, Pirooznia M, Ruczinski I, Nestadt G, Kenny EE, Vacic V, Peters I, Lencz T, Darvasi A, Mulle JG, Warren ST, Pulver AE. Genome-wide association study of schizophrenia in Ashkenazi Jews. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 168: 649-59. PMID 26198764 DOI: 10.1002/Ajmg.B.32349 |
0.641 |
|
2015 |
Ramachandran D, Zeng Z, Locke AE, Mulle JG, Bean LJ, Rosser TC, Dooley KJ, Cua CL, Capone GT, Reeves RH, Maslen CL, Cutler DJ, Feingold E, Sherman SL, Zwick ME. Genome-Wide Association Study of Down Syndrome-Associated Atrioventricular Septal Defects. G3 (Bethesda, Md.). 5: 1961-71. PMID 26194203 DOI: 10.1534/G3.115.019943 |
0.801 |
|
2015 |
Mulle J. The 3q29 deletion confers >40-fold increase in risk for schizophrenia. Molecular Psychiatry. 20: 1028-1029. PMID 26055425 DOI: 10.1038/Mp.2015.76 |
0.418 |
|
2015 |
Avramopoulos D, Pearce BD, McGrath J, Wolyniec P, Wang R, Eckart N, Hatzimanolis A, Goes FS, Nestadt G, Mulle J, Coneely K, Hopkins M, Ruczinski I, Yolken R, Pulver AE. Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. Plos One. 10: e0116696. PMID 25781172 DOI: 10.1371/Journal.Pone.0116696 |
0.419 |
|
2015 |
Ramachandran D, Mulle JG, Locke AE, Bean LJ, Rosser TC, Bose P, Dooley KJ, Cua CL, Capone GT, Reeves RH, Maslen CL, Cutler DJ, Sherman SL, Zwick ME. Contribution of copy-number variation to Down syndrome-associated atrioventricular septal defects. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 17: 554-60. PMID 25341113 DOI: 10.1038/Gim.2014.144 |
0.773 |
|
2014 |
Satten GA, Allen AS, Ikeda M, Mulle JG, Warren ST. Robust regression analysis of copy number variation data based on a univariate score. Plos One. 9: e86272. PMID 24516529 DOI: 10.1371/Journal.Pone.0086272 |
0.74 |
|
2014 |
Mulle JG, Pulver AE, McGrath JA, Wolyniec PS, Dodd AF, Cutler DJ, Sebat J, Malhotra D, Nestadt G, Conrad DF, Hurles M, Barnes CP, Ikeda M, Iwata N, Levinson DF, et al. Reciprocal duplication of the Williams-Beuren syndrome deletion on chromosome 7q11.23 is associated with schizophrenia. Biological Psychiatry. 75: 371-7. PMID 23871472 DOI: 10.1016/J.Biopsych.2013.05.040 |
0.685 |
|
2013 |
Goldlust IS, Hermetz KE, Catalano LM, Barfield RT, Cozad R, Wynn G, Ozdemir AC, Conneely KN, Mulle JG, Dharamrup S, Hegde MR, Kim KH, Angle B, Colley A, Webb AE, et al. Mouse model implicates GNB3 duplication in a childhood obesity syndrome. Proceedings of the National Academy of Sciences of the United States of America. 110: 14990-4. PMID 23980137 DOI: 10.1073/Pnas.1305999110 |
0.373 |
|
2013 |
Moreno-De-Luca D, Sanders SJ, Willsey AJ, Mulle JG, Lowe JK, Geschwind DH, State MW, Martin CL, Ledbetter DH. Using large clinical data sets to infer pathogenicity for rare copy number variants in autism cohorts. Molecular Psychiatry. 18: 1090-5. PMID 23044707 DOI: 10.1038/Mp.2012.138 |
0.404 |
|
2012 |
Mulle JG. Schizophrenia genetics: progress, at last. Current Opinion in Genetics & Development. 22: 238-244. PMID 22424801 DOI: 10.1016/J.Gde.2012.02.011 |
0.424 |
|
2012 |
Kenny EE, Pe'er I, Karban A, Ozelius L, Mitchell AA, Ng SM, Erazo M, Ostrer H, Abraham C, Abreu MT, Atzmon G, Barzilai N, Brant SR, Bressman S, Burns ER, ... ... Mulle J, et al. A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. Plos Genetics. 8: e1002559. PMID 22412388 DOI: 10.1371/Journal.Pgen.1002559 |
0.608 |
|
2012 |
Mulle JG, Warren ST. Genomic tics in tourette syndrome. Biological Psychiatry. 71: 390-1. PMID 22310325 DOI: 10.1016/J.Biopsych.2011.12.017 |
0.629 |
|
2011 |
Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 13: 777-84. PMID 21844811 DOI: 10.1097/Gim.0B013E31822C79F9 |
0.613 |
|
2011 |
Luo Y, Hermetz KE, Jackson JM, Mulle JG, Dodd A, Tsuchiya KD, Ballif BC, Shaffer LG, Cody JD, Ledbetter DH, Martin CL, Rudd MK. Diverse mutational mechanisms cause pathogenic subtelomeric rearrangements. Human Molecular Genetics. 20: 3769-78. PMID 21729882 DOI: 10.1093/Hmg/Ddr293 |
0.434 |
|
2011 |
Moreno-De-Luca D, Mulle JG, Kaminsky EB, Sanders SJ, Myers SM, Adam MP, Pakula AT, Eisenhauer NJ, Uhas K, Weik L, Guy L, Care ME, Morel CF, Boni C, Salbert BA, et al. Erratum: Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia (The American Journal of Human Genetics (2010) 87 (618-630)) American Journal of Human Genetics. 88. DOI: 10.1016/J.Ajhg.2010.12.005 |
0.648 |
|
2010 |
Moreno-De-Luca D, Mulle JG, Kaminsky EB, Sanders SJ, Myers SM, Adam MP, Pakula AT, Eisenhauer NJ, Uhas K, Weik L, Guy L, Care ME, et al. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. American Journal of Human Genetics. 87: 618-30. PMID 21055719 DOI: 10.1016/J.Ajhg.2010.10.004 |
0.657 |
|
2010 |
Bray SM, Mulle JG, Dodd AF, Pulver AE, Wooding S, Warren ST. Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population. Proceedings of the National Academy of Sciences of the United States of America. 107: 16222-7. PMID 20798349 DOI: 10.1073/Pnas.1004381107 |
0.644 |
|
2010 |
Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, Sobreira NL, Valle D, Rudd MK, Satten G, Cutler DJ, Pulver AE, Warren ST. Microdeletions of 3q29 confer high risk for schizophrenia. American Journal of Human Genetics. 87: 229-36. PMID 20691406 DOI: 10.1016/J.Ajhg.2010.07.013 |
0.689 |
|
2010 |
Mulle JG, Patel VC, Warren ST, Hegde MR, Cutler DJ, Zwick ME. Empirical evaluation of oligonucleotide probe selection for DNA microarrays. Plos One. 5: e9921. PMID 20360966 DOI: 10.1371/Journal.Pone.0009921 |
0.528 |
|
2009 |
Rudd MK, Keene J, Bunke B, Kaminsky EB, Adam MP, Mulle JG, Ledbetter DH, Martin CL. Segmental duplications mediate novel, clinically relevant chromosome rearrangements. Human Molecular Genetics. 18: 2957-62. PMID 19443486 DOI: 10.1093/Hmg/Ddp233 |
0.471 |
|
2009 |
Arlt MF, Mulle JG, Schaibley VM, Ragland RL, Durkin SG, Warren ST, Glover TW. Replication Stress Induces Genome-wide Copy Number Changes in Human Cells that Resemble Polymorphic and Pathogenic Variants American Journal of Human Genetics. 84: 339-350. PMID 19232554 DOI: 10.1016/J.Ajhg.2009.01.024 |
0.604 |
|
2008 |
Hegde MR, Chin EL, Mulle JG, Okou DT, Warren ST, Zwick ME. Microarray-based mutation detection in the dystrophin gene. Human Mutation. 29: 1091-9. PMID 18663755 DOI: 10.1002/Humu.20831 |
0.556 |
|
2008 |
Durkin SG, Ragland RL, Arlt MF, Mulle JG, Warren ST, Glover TW. Replication stress induces tumor-like microdeletions in FHIT/FRA3B Proceedings of the National Academy of Sciences of the United States of America. 105: 246-251. PMID 18162546 DOI: 10.1073/Pnas.0708097105 |
0.596 |
|
2007 |
Penagarikano O, Mulle JG, Warren ST. The pathophysiology of fragile X syndrome Annual Review of Genomics and Human Genetics. 8: 109-129. PMID 17477822 DOI: 10.1146/Annurev.Genom.8.080706.092249 |
0.757 |
|
2007 |
Mulle JG, Fallin MD, Lasseter VK, McGrath JA, Wolyniec PS, Pulver AE. Dense SNP association study for bipolar I disorder on chromosome 18p11 suggests two loci with excess paternal transmission. Molecular Psychiatry. 12: 367-75. PMID 17389904 DOI: 10.1038/Sj.Mp.4001916 |
0.372 |
|
2007 |
Mulle J, Penagarikano O, Warren ST. Path to understanding the pathophysiology of fragile X syndrome Future Neurology. 2: 567-575. DOI: 10.2217/14796708.2.5.567 |
0.58 |
|
2005 |
Mulle JG, McDonough JA, Chowdari KV, Nimgaonkar V, Chakravarti A. Evidence for linkage to chromosome 13q32 in an independent sample of schizophrenia families Molecular Psychiatry. 10: 429-431+423. PMID 15738936 DOI: 10.1038/Sj.Mp.4001639 |
0.401 |
|
2000 |
Pulver AE, Mulle J, Nestadt G, Swartz KL, Blouin JL, Dombroski B, Liang KY, Housman DE, Kazazian HH, Antonarakis SE, Lasseter VK, Wolyniec PS, Thornquist MH, McGrath JA. Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes. Molecular Psychiatry. 5: 650-3. PMID 11126395 DOI: 10.1038/Sj.Mp.4000814 |
0.437 |
|
Show low-probability matches. |